- Report
- June 2026
- 464 Pages
Global
From €5314EUR$5,850USD£4,587GBP
- Drug Pipelines
- April 2026
- 280 Pages
Global
From €2725EUR$3,000USD£2,352GBP
- Clinical Trials
- April 2026
- 450 Pages
Global
From €4542EUR$5,000USD£3,920GBP
- Report
- December 2025
- 200 Pages
Global
From €7222EUR$7,950USD£6,233GBP
- Report
- July 2025
- 350 Pages
Global
From €4496EUR$4,949USD£3,880GBP
- Report
- April 2026
- 305 Pages
Global
From €2271EUR$2,500USD£1,960GBP
- Report
- April 2026
- 160 Pages
Global
From €3770EUR$4,150USD£3,254GBP
- Report
- April 2026
- 160 Pages
Global
From €3770EUR$4,150USD£3,254GBP
- Report
- April 2026
- 160 Pages
Global
From €3770EUR$4,150USD£3,254GBP
- Report
- May 2026
- 150 Pages
Global
From €5405EUR$5,950USD£4,665GBP
- Report
- May 2026
- 150 Pages
Global
From €5405EUR$5,950USD£4,665GBP
- Report
- June 2026
- 194 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 188 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- June 2026
- 197 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- June 2026
- 190 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- June 2026
- 186 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 198 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 194 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- January 2026
- 185 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP
- Report
- August 2025
- 182 Pages
Global
From €3220EUR$3,545USD£2,779GBP
€3578EUR$3,939USD£3,088GBP

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides.
Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more